Pfizer Market Cap History
Below is a table of the Pfizer market cap history going back to 2/18/2010:

Date PFE Market Cap
2/18/2010143.09B
5/10/2010137.12B
8/9/2010131.99B
11/8/2010136.57B
2/22/2011151.03B
5/9/2011162.76B
8/8/2011129.98B
11/7/2011154.28B
2/21/2012159.97B
5/7/2012168.11B
8/6/2012181.21B
11/5/2012180.97B
2/21/2013197.05B
5/6/2013203.72B
8/5/2013193.25B
11/4/2013202.60B
2/21/2014200.81B
5/5/2014191.11B
8/4/2014182.30B
11/3/2014190.22B
2/20/2015211.81B
5/4/2015211.33B
8/3/2015222.95B
11/2/2015216.43B
2/25/2016189.17B
5/9/2016205.11B
8/8/2016211.87B
11/7/2016184.36B
2/21/2017200.10B
5/8/2017199.62B
8/7/2017198.11B
11/6/2017210.53B
2/20/2018214.36B
5/7/2018204.33B
8/6/2018240.58B
11/5/2018251.57B
2/26/2019238.84B

Also see: PFE Shares Outstanding History
and PFE YTD Return
Pfizer Historical Market Cap:
+5.84% CAGR
Pfizer Historical Market Cap: +5.84% CAGR

Mouse over chart for data details
2/18/2010 ...2/26/2019
Pfizer is a research-based biopharmaceutical company. Co.'s portfolio includes medicines and vaccines, as well as consumer healthcare products. Co. manages its commercial operations through three businesses: Pfizer Biopharmaceuticals Group, which includes Co.'s health business units (except Consumer Healthcare) as well as a hospital business unit that commercializes its portfolio of sterile injectable and anti-infective medicines; Upjohn, which includes Co.'s solid oral dose brands such as Lyrica, Lipitor, Norvasc, Viagra and Celebrex, as well as certain generic medicines; and Consumer Healthcare, which is an over-the-counter medicines business. We show 37 historical shares outstanding datapoints in our PFE shares outstanding history coverage, used to compute PFE market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing Pfizer market cap history over the course of time is important for investors interested in comparing Pfizer's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of Pfizer versus a peer is one thing; comparing Pfizer market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like Pfizer can fluctuate over the course of history. With this page we aim to empower investors researching Pfizer by allowing them to research the Pfizer market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for PFE:
PFE SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Pfizer (PFE) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

PGNX Market Cap History
PIRS Market Cap History
PKI Market Cap History
PLSE Market Cap History
PLXP Market Cap History
PMD Market Cap History
PODD Market Cap History
PRAH Market Cap History
PRGO Market Cap History
PRPH Market Cap History
More Healthcare companies »

 

Pfizer Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2019, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.